Table 3.
Results of multivariate Cox proportional-hazards regression analyzing the effect of baseline variables on in-hospital death
| Mode | HR (95%CI) | P |
|---|---|---|
| Not Adjusted NT-proBNP, per 100 pg/ml | 1.369 (1.217–1.541) | < 0.001 |
| Mode 1 | ||
| NT-proBNP, per 100 pg/ml | 1.323 (1.119–1.563) | 0.001 |
| Female vs. Male | 1.077 (0.330–3.518) | 0.902 |
| Age, per 10 years | 1.176 (0.719–1.922) | 0.518 |
| Mode 2 | ||
| NT-proBNP, per 100 pg/ml | 1.342 (1.185–1.520) | < 0.001 |
| HP, yes vs. no | 1.613 (0.591–4.406) | 0.351 |
| CHD, yes vs. no | 1.219 (0.422–3.521) | 0.714 |
| Mode 3 | ||
| NT-proBNP, per 100 pg/ml | 1.360 (1.177–1.572) | < 0.001 |
| MYO, per 1 ng/ml | 1.001 (0.996–1.005) | 0.773 |
| CK-MB, per 1 μg/L | 1.119 (0.905–1.385) | 0.299 |
| Hs-TnI, per 0.1 ng/ml | 1.031 (0.574–1.855) | 0.918 |
| Mode 4 | ||
| NT-proBNP, per 100 pg/ml | 1.373 (1.188–1.586) | < 0.001 |
| Urea, per 1 mmol/L | 1.041 (0.936–1.158) | 0.460 |
| Creatinine, per 1 umol/L | 0.999 (0.974–1.025) | 0.957 |
| Mode 5 | ||
| NT-proBNP, per 100 pg/ml | 1.248 (1.097–1.419) | 0.001 |
| WBC, per 1 × 109/L | 1.099 (1.015–1.190) | 0.021 |
| LYM, per 1 × 109/L | 0.163 (0.035–0.761) | 0.021 |
| Mode 6 | ||
| NT-proBNP, per 100 pg/ml | 1.230 (1.003–1.509) | 0.047 |
| WBC, per 1 × 109/L | 1.036 (0.903–1.189) | 0.611 |
| LYM, per 1 × 109/L | 0.201 (0.033–1.221) | 0.081 |
| CRP, per 1 mg/L | 1.011 (0.999–1.023) | 0.066 |
| Mode 7 | ||
| NT-proBNP, per 100 pg/ml | 1.200 (1.045–1.380) | 0.010 |
| WBC, per 1 × 109/L | 1.088 (0.016–1.164) | 0.016 |
| LYM, per 1 × 109/L | 0.151 (0.029–0.778) | 0.024 |
| PCT, per 0.1 ng/ml | 1.110 (1.010–1.220) | 0.030 |
Abbreviations: NT-proBNP N-terminal pro-brain natriuretic peptide, HP Hypertension, CHD Coronary heart disease, MYO Myoglobin, CK-MB Creatine kinase-MB, Hs-TnI High-sensitivity troponin-I, WBC White blood cell, LYM Lymphocytes, CRP C-reactive protein, PCT Procalcitonin, HR Hazards ratio; 95%CI 95% confidence interval